Advertisement
Table 1 Demographic characteristics of chronic hepatitis C patients after therapy
| Demographic factorsa | |||||
|---|---|---|---|---|---|
| Gender | |||||
| Mean years of age (SD) | Females | Males | Mean BMI (SD) | Viral loadc | |
| Australian cohort (n = 312,313) | |||||
| SVR (n = 130) | 40.0 a (9.6) | 52 b (40.0) | 78 b (60.0) | 26.927.0 (4.85.1) | P = NS |
| NSVR (n = 182,183) | 44.5 4 a (7.12) | 42 43 b (23.15) | 140 b (76.95) | 27.4 (5.32) | |
| Berlin cohort (n = 310,307) | |||||
| SVR (n = 150,149) | 41.0 (10.5) | 79 78 (52.73) | 71 (47.37) | 25.1 (4.5) | P < 0.05001 |
| NSVR (n = 15,860) | 46.7 8 (10.34) | 69 68 (43.10) | 91 90 (55.97.0) | 25.9 (3.9) | |
| Newcastle UK cohort (n = 6,990) | |||||
| SVR (n = 3,140) | 3837.2 a (11.86) | 9 12 (29.030.0) | 22 28 (7170.0) | 25.23.7 (3.96.3) | P ≤ 0.05002 |
| NSVR (n = 5,038) | 46.0 a (1210.0) | 10 12 (26.324.0) | 28 38 (73.776.0) | 26.227.0 (6.64.8) | |
| Bonn cohort (n = 57) | |||||
| SVR (n = 26) | 44.7 (12.9) | 11 (42.3) | 15 (57.7) | 25.4 (4.23) | P ≤ 0.05008 |
| NSVR (n = 31) | 50.8 (10.9) | 11 (35.5) | 20 (64.5) | 27.3 (4.6) | |
| Trent UK cohort (n = 4,843) | |||||
| SVR (n = 2,221) | 39.843.5 (9.80) | 6 5 (27.323.8) | 16 (72.776.2) | 26.97.1 (3.57) | NS |
| NSVR (n = 2,622) | 45.747.4 (7.99.3) | 5 4 (1918.2) | 21 18 (8081.8) | 2526.0 (2.93.5) | |
| Turin cohort (n = 11,495) | |||||
| SVR (n = 5,845) | 41.63.3 (13.10) | 28 18 (48.340.0) | 30 27 (51.760.0) | 24.023.9 (3.23) | P ≤ 0.0502 |
| NSVR (n = 5,650) | 45.1 7 (10.09.7) | 19 (33.938.0) | 37 31 (66.162.0) | 24.5 6 (3.34) | |
| Total cohort (n = 910,905) | |||||
| SVR (n = 417,411) | 40.9 6 a (10.87) | 185 176 b (44.442.8) | 232 235 b (55.657.2) | 25.5 7 (4.75) | P < 0.05001 |
| NSVR (n = 493,494) | 45.7b 8 a (9.32) | 156b 157 b (31.68) | 337 b (68.42) | 26.3 5 (4.76) | |
